J.P. Morgan Updates On CAH

J.P. Morgan has released an update on Cardinal Health (NYSE: CAH) before its conference call tomorrow.

In the report J.P. Morgan writes, "Acute-care distribution is the largest business within the medical segment, and we estimate it represents roughly 75% of segment revenue. Cardinal has 32% market share, second to Owens & Minor with 40% share. The share of sales flowing through the distribution channel is roughly 25% today, as a number of high-priced high-touch specialized medical products are sold and distributed directly by manufacturers."

CAH has an Overweight Rating and a Price Target of $44.00.

CAH was trading at $40.90 at closing yesterday.